These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 20519180)

  • 1. [Pathomechanism of diabetic neuropathy: background of the pathogenesis-oriented therapy].
    Winkler G; Kempler P
    Orv Hetil; 2010 Jun; 151(24):971-81. PubMed ID: 20519180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in the management of diabetic neuropathy.
    Várkonyi T; Körei A; Putz Z; Martos T; Keresztes K; Lengyel C; Nyiraty S; Stirban A; Jermendy G; Kempler P
    Minerva Med; 2017 Oct; 108(5):419-437. PubMed ID: 28541026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of Oxidative Stress in Diabetic Neuropathy: Generation of Free Radical Species in the Glycation Reaction and Gene Polymorphisms Encoding Antioxidant Enzymes to Genetic Susceptibility to Diabetic Neuropathy in Population of Type I Diabetic Patients.
    Babizhayev MA; Strokov IA; Nosikov VV; Savel'yeva EL; Sitnikov VF; Yegorov YE; Lankin VZ
    Cell Biochem Biophys; 2015 Apr; 71(3):1425-43. PubMed ID: 25427889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current options and perspectives in the treatment of diabetic neuropathy.
    Várkonyi T; Putz Z; Keresztes K; Martos T; Lengyel C; Stirban A; Jermendy G; Kempler P
    Curr Pharm Des; 2013; 19(27):4981-5007. PubMed ID: 23278494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha-lipoic acid in the treatment of autonomic diabetic neuropathy (controlled, randomized, open-label study).
    Tankova T; Koev D; Dakovska L
    Rom J Intern Med; 2004; 42(2):457-64. PubMed ID: 15529636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benfotiamine alleviates diabetes-induced cerebral oxidative damage independent of advanced glycation end-product, tissue factor and TNF-alpha.
    Wu S; Ren J
    Neurosci Lett; 2006 Feb; 394(2):158-62. PubMed ID: 16260089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetic neuropathy: new strategies for treatment.
    Várkonyi T; Kempler P
    Diabetes Obes Metab; 2008 Feb; 10(2):99-108. PubMed ID: 17593238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy.
    Hammes HP; Du X; Edelstein D; Taguchi T; Matsumura T; Ju Q; Lin J; Bierhaus A; Nawroth P; Hannak D; Neumaier M; Bergfeld R; Giardino I; Brownlee M
    Nat Med; 2003 Mar; 9(3):294-9. PubMed ID: 12592403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of α-lipoic acid in diabetic neuropathy.
    Papanas N; Ziegler D
    Expert Opin Pharmacother; 2014 Dec; 15(18):2721-31. PubMed ID: 25381809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The pathogenesis of diabetic and hepatic neuropathies].
    Winkler G; Kempler P
    Orv Hetil; 2001 Nov; 142(45):2459-67. PubMed ID: 11778353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thioctic acid for patients with symptomatic diabetic polyneuropathy: a critical review.
    Ziegler D
    Treat Endocrinol; 2004; 3(3):173-89. PubMed ID: 16026113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral benfotiamine plus alpha-lipoic acid normalises complication-causing pathways in type 1 diabetes.
    Du X; Edelstein D; Brownlee M
    Diabetologia; 2008 Oct; 51(10):1930-2. PubMed ID: 18663426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of alpha-lipoic acid on symptoms and skin blood flow in diabetic neuropathy.
    Jin HY; Joung SJ; Park JH; Baek HS; Park TS
    Diabet Med; 2007 Sep; 24(9):1034-8. PubMed ID: 17490418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidative stress and diabetic neuropathy: pathophysiological mechanisms and treatment perspectives.
    van Dam PS
    Diabetes Metab Res Rev; 2002; 18(3):176-84. PubMed ID: 12112935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Neurometabolic therapy of diabetic neuropathy].
    Medvedeva LA; Gnezdilov AV; Zagorul'ko OI; Syrovegin AV; Samoĭlova NV; Slashchuk IuI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2006; 106(7):71-3. PubMed ID: 16921725
    [No Abstract]   [Full Text] [Related]  

  • 16. Diabetic Neuropathy: Update on Pathophysiological Mechanism and the Possible Involvement of Glutamate Pathways.
    Hussain N; Adrian TE
    Curr Diabetes Rev; 2017; 13(5):488-497. PubMed ID: 27341846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha-lipoic acid in the treatment of diabetic polyneuropathy in Germany: current evidence from clinical trials.
    Ziegler D; Reljanovic M; Mehnert H; Gries FA
    Exp Clin Endocrinol Diabetes; 1999; 107(7):421-30. PubMed ID: 10595592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetic neuropathy and oxidative stress: therapeutic perspectives.
    Hosseini A; Abdollahi M
    Oxid Med Cell Longev; 2013; 2013():168039. PubMed ID: 23738033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Switching from pathogenetic treatment with alpha-lipoic acid to gabapentin and other analgesics in painful diabetic neuropathy: a real-world study in outpatients.
    Ruessmann HJ;
    J Diabetes Complications; 2009; 23(3):174-7. PubMed ID: 18403218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in understanding the role of oxidative stress in diabetic neuropathy.
    Shakeel M
    Diabetes Metab Syndr; 2015; 9(4):373-8. PubMed ID: 25470637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.